These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2902130)

  • 1. Recent experience with Pseudomonas aeruginosa immune globulin for the treatment of experimental pneumonia.
    Pennington JE
    J Hosp Infect; 1988 Aug; 12 Suppl D():55-60. PubMed ID: 2902130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15(1):56-9. PubMed ID: 3106230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15 Suppl 2():S47-50. PubMed ID: 3112020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Small GJ; Lostrom ME; Pier GB
    Infect Immun; 1986 Oct; 54(1):239-44. PubMed ID: 3093385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M
    J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
    Minukhin VV; Tsyganenko AIa
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Pseudomonas immunoglobulin in artificially respirated patients at an interdisciplinary surgical intensive care unit].
    Class I; Junginger W; Klöss T
    Infection; 1987; 15(1):76-9. PubMed ID: 3106233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV; Tsyganenko VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of molecular biology on Pseudomonas aeruginosa immunization.
    Pennington JE
    J Hosp Infect; 1988 Feb; 11 Suppl A():96-102. PubMed ID: 2896754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
    Minukhin VV; Tsyganenko AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):90-2. PubMed ID: 3098009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA; Naglich JG
    Am J Med; 1984 Mar; 76(3A):161-7. PubMed ID: 6424445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G: potentiation of tobramycin and azlocillin in the treatment of Pseudomonas aeruginosa sepsis in neutropenic mice and neutralization of exotoxin A in vivo.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Rev Infect Dis; 1986; 8 Suppl 4():S420-5. PubMed ID: 3092309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE
    Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL; Purdue GF
    J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
    Pennington JE; Hickey WF; Blackwood LL; Arnaut MA
    J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
    Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J
    Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.